Abstract
Genetic modification of human lymphocytes is being employed in strategies to correct enzyme deficiencies, encode cytokines and to redirect lymphocytes to antigenic targets other than those encoded by their endogenous T cell receptor. However, expression of transgenes in primary lymphocytes is generally low. Reasoning that vector modification may lead to increased transgene expression and subsequent increases in function, we have performed two retroviral vector modifications and report their effect on the functional expression in primary lymphocytes. A chimeric receptor specific for the colon carcinoma-associated antigen, EGP40, was initially incorporated into the retroviral vector LXSN. In this vector, receptor expression is driven by the Moloney murine leukemia virus LTR, and neomycin phosphotransferase expression driven by the SV40 promoter. Replacement of SV40 with an internal ribosomal entry site (IRES) increased the transgene activity of a mouse T cell line and human PBL as judged by increased cytokine release in response to antigen positive target cells. A further increase in transgene function was generated by the additional incorporation of a splice acceptor motif into the construct. Human PBL transduced with vector incorporating both IRES and intron were consistently more effective at lysing antigen positive colorectal carcinoma cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kay MA, Glorioso JC, Naldini L . Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics Nat Med 2001 7: 33–40
Kim SH et al. Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4 J Immunol 2001 66: 3499–3505
Yonemitsu Y et al. Efficient gene transfer to airway epithelium using recombinant Sendai virus Nat Biotechnol 2000 8: 970–973
Kim SH, Kim S, Robbins PD . Retroviral vectors Adv Virus Res 2000 55: 545–563
Kim SH, Kim S, Robbins PD . Retroviral vectors Hwu P, Rosenberg SA. Gene therapy of cancer. In: DeVita VT, Hellman S, Rosenberg SA (eds). Principles and Practice of Oncology fifth edn. Philadelphia, Lippincott: Philadelphia, 1997, pp 3005–3002.•<aq4>•
Hwu P et al. In vivo antitumor activity of T cells redirected with chimeric antibody/T cell receptor genes Cancer Res 1995 55: 3369–3373
Moritz D, Wels W, Mattern J, Groner B . Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells Proc Natl Acad Sci USA 1994 91: 4318–4322
Hekele A et al. Growth retardation of tumors by adoptive transfer of cytotoxic T lymphocytes reprogrammed by CD44v6-specific scFv:zeta-chimera Int J Cancer 1996 68: 232–238
Velders MP et al. New chimeric anti-pancarcinoma monoclonal antibody with superior cytotoxicity-mediating potency (published erratum appears in Cancer Res 1994; 54: 2821) Cancer Res 1994 54: 1753–1759
Daly T et al. Recognition of human colon cancer by T cells transduced with a chimeric receptor gene Cancer Gene Ther 2000 7: 284–291
Jang SK et al. Cap-independent translation of picornavirus RNAs: structure and function of the internal ribosomal entry site Enzyme 1990 44: 292–309
Kim DG, Kang HM, Jang SK, Shin HS . Construction of a bifunctional mRNA in the mouse by using the internal ribosomal entry site of the encephalomyocarditis virus (published erratum appears in Mol Cell Biol 1992; 12: 4807) Mol Cell Biol 1992 12: 3636–3643
Brinster RL et al. Introns increase transcriptional efficiency in transgenic mice Proc Natl Acad Sci USA 1988 85: 836–840
Chung S, Perry RP . Importance of introns for expression of mouse ribosomal protein gene rpL32 Mol Cell Biol 1989 9: 2075–2082
Miller AD, Rosman GJ . Improved retroviral vectors for gene transfer and expression Biotechniques 1989 7: 980–986
Morgan RA et al. Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy Nucleic Acids Res 1992 20: 1293–1299
Chuah MK, Vandendriessche T, Morgan RA . Development and analysis of retroviral vectors expressing human factor VIII as a potential gene therapy for hemophilia A Hum Gene Ther 1995 6: 1363–1377
Schwartzentruber DJ et al. In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2 J Clin Oncol 1994 12: 1475–1483
Blaese RM et al. T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years Science 1995 270: 475–480
Tran AC, Zhang D, Byrn R, Roberts MR . Chimeric zeta-receptors direct human natural killer (NK) effector function to permit killing of NK-resistant tumor cells and HIV-infected T lymphocytes J Immunol 1995 155: 1000–1009
Weijtens ME et al. Single chain Ig/gamma gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lytic capacity J Immunol 1996 157: 836–843
Eshhar Z . Tumor-specific T-bodies: towards clinical application Cancer Immunol Immunother 1997 45: 131–136
Daly T . Recognition of human colon cancer by T cells transduced with a chimeric receptor gene Cancer Gene Ther 2000 7: 284–291
Herlyn D et al. Efficient selection of human tumor growth-inhibiting monoclonal antibodies J Immunol Meth 1984 73: 157–167
Hwu P et al. Functional and molecular characterization of tumor-infiltrating lymphocytes transduced with tumor necrosis factor-alpha cDNA for the gene therapy of cancer in humans J Immunol 1993 150: 4104–4115
Rosenberg SA et al. The development of gene therapy for the treatment of cancer Ann Surg 1993 218: 455–463
Treisman J et al. Upregulation of tumor necrosis factor-alpha production by retrovirally transduced human tumor-infiltrating lymphocytes using trans-retinoic acid Cell Immunol 1994 156: 448–457
Rudoll T et al. High-efficiency retroviral vector mediated gene transfer into human peripheral blood CD4+ T lymphocytes Gene Therapy 1996 3: 695–705
Bunnell BA et al. High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes Proc Natl Acad Sci USA 1995 92: 7739–7743
Lam JS et al. Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope Hum Gene Ther 1996 7: 1415–1422
Miller AD et al. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus J Virol 1991 65: 2220–2224
Ramesh N, Shin YK, Lau S, Osborne WR . High-level expression from a cytomegalovirus promoter in macrophage cells Hum Gene Ther 1995 6: 1323–1327
Malik P et al. Retroviral-mediated gene expression in human myelomonocytic cells: a comparison of hematopoietic cell promoters to viral promoters Blood 1995 86: 2993–3005
Correll PH, Colilla S, Karlsson S . Retroviral vector design for long-term expression in murine hematopoietic cells in vivo Blood 1994 84: 1812–1822
Yoshimatsu T, Tamura M, Kuriyama S, Ikenaka K . Improvement of retroviral packaging cell lines by introducing the polyomavirus early region Hum Gene Ther 1998 9: 161–172
Hawley TS, Sabourin LA, Hawley RG . Comparative analysis of retroviral vector expression in mouse embryonal carcinoma cells Plasmid 1989 22: 120–131
Gallardo HF, Tan C, Sadelain M . The internal ribosomal entry site of the encephalomyocarditis virus enables reliable coexpression of two transgenes in human primary T lymphocytes Gene Therapy 1997 4: 1115–1119
Staal FJ et al. Use of bicistronic retroviral vectors encoding the LacZ gene together with a gene of interest: a method to select producer cells and follow transduced target cells Cancer Gene Ther 1996 3: 345–351
Treisman J et al. Interleukin-2-transduced lymphocytes grow in an autocrine fashion and remain responsive to antigen Blood 1995 85: 139–145
Viola A, Lanzavecchia A . T cell activation determined by T cell receptor number and tunable thresholds Science 1996 273: 104–106
Acknowledgements
MHK was supported by National Health and Medical Research Council of Australia, CJ Martin Postdoctoral Fellowship. TD and JL were sponsored by Howard Hughes Medical Institute-National Institutes of Health Research Scholars Program, Howard Hughes Medical Institute, Bethesda, MD, 20892.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Royal, R., Kershaw, M., Reeves, M. et al. Increased functional expression of transgene in primary human lymphocytes using retroviral vectors modified with IRES and splicing motifs. Gene Ther 9, 1085–1092 (2002). https://doi.org/10.1038/sj.gt.3301734
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301734
Keywords
This article is cited by
-
Co-expression of α(1,3)galactosyltransferase and Bacillus thuringiensis PIPLC enhances hyperacute rejection of tumor cells
Cancer Immunology, Immunotherapy (2006)
-
Optimization of equine infectious anemia derived vectors for hematopoietic cell lineage gene transfer
Gene Therapy (2005)